Peer-influenced content. Sources you trust. No registration required. This is HCN.

Dentistry TodayOverjet Expands Dental AI Detection Capabilities with 4th FDA Clearance

The FDA study revealed that dentists detected 43% fewer teeth with caries on bitewing images and 45.8% fewer teeth with caries on periapical images when using Overjet.


Overjet, a pioneer in dental AI technology, has achieved a significant milestone with its fourth FDA clearance, broadening the scope of its AI capabilities in predicting tooth decay in patients aged 12 and older with permanent teeth.

Key Points:

  • Overjet is the only dental AI technology that outlines decay, aiding in diagnosis, treatment planning, and patient discussions.
  • Overjet’s previous FDA clearance for Caries Assist was recognized as a world-changing idea for 2023 by Fast Company.

Additional Points:

  • The AI technology is also FDA-cleared to detect calculus, quantify bone level measurements, and assess the level of periodontal disease.
  • Overjet’s AI integrates with digital imaging and practice management systems to analyze past patient records and provide additional insights for patient care.

Conclusion:

  • Overjet’s AI technology is revolutionizing the dental industry by enhancing the detection and treatment of tooth decay, thereby improving oral health care.

Dentistry A-Z

“Untreated cavities can lead to problems with eating, speaking, self-esteem, and quality of life. Our goal is to improve oral health care for all, and expanding Overjet’s AI detection capabilities gives dentists another advantage to help provide the best care possible.”

Wardah Inam
CEO/Co-founder
Overjet
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form